December 22, 2020
Tagrisso Approved as Adjuvant Therapy for NSCLC With EGFR Mutations
TUESDAY, Dec. 22, 2020 (HealthDay News) — Tagrisso (osimertinib) received approval as an adjuvant treatment for patients with non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, the U.S. Food and Drug Administration announced Friday. The current approval of the once-daily oral tablet is indicated for...
CDC: Life Expectancy for U.S. Population Increased in 2019
TUESDAY, Dec. 22, 2020 (HealthDay News) — Life expectancy for the U.S. population increased in 2019, while the rate of drug overdose deaths increased from 2018 to 2019, according to two December data briefs published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics. Kenneth D. Kochanek, from the National...
Outcomes Similar With Aflibercept, Vitrectomy for Vitreous Hemorrhage
TUESDAY, Dec. 22, 2020 (HealthDay News) — For patients with proliferative diabetic retinopathy with vitreous hemorrhage, most outcomes do not differ significantly for initial treatment with intravitreous aflibercept or vitrectomy with panretinal photocoagulation, according to a study published in the Dec. 15 issue of the Journal of the American Medical Association. Andrew N. Antoszyk, M.D.,...